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In Brief
The principles underlying switch-like and
irreversible transitions between cell-cycle
phases are poorly understood in
mammalian cells. Barr et al. have used
quantitative real-time imaging of
regulators of the G1-to-S transition in
single human cells to develop a
mechanistic model to show how this
network drives rapid and irreversible
commitment to cell-cycle progression.
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The transition from G1 into DNA replication (S phase)
is an emergent behavior resulting from dynamic and
complex interactions between cyclin-dependent
kinases (Cdks), Cdk inhibitors (CKIs), and the
anaphase-promoting complex/cyclosome (APC/C).
Understanding the cellular decision to commit to
S phase requires a quantitative description of these
interactions. We apply quantitative imaging of single
human cells to track the expression of G1/S regula-
tors and use these data to parametrize a stochastic
mathematical model of the G1/S transition. We
show that a rapid, proteolytic, double-negative feed-
back loop betweenCdk2:Cyclin and the Cdk inhibitor
p27Kip1 drives a switch-like entry into S phase.
Furthermore, our model predicts that increasing
Emi1 levels throughout S phase are critical in main-
taining irreversibility of the G1/S transition, which
we validate using Emi1 knockdown and live imaging
of G1/S reporters. This work provides insight into the
general design principles of the signaling networks
governing the temporally abrupt transitions between
cell-cycle phases.
INTRODUCTION
Through decades of painstaking genetic and biochemical
research, the components regulating cell-cycle progression
have been identified, but how these components dynamically
interact to drive this progression in either normal or cancerous
human cells is poorly understood. In mammalian cells, the deci-
sion to enter the cell cycle is made at the restriction point, which
is analogous to the Start transition in yeast (Johnson and Sko-
theim, 2013; Zetterberg et al., 1995). Restriction point/Start is fol-
lowed by a separate G1/S transition where the cell becomes
committed to DNA replication. In yeast, Start is characterized
by a transcriptional burst that leads to the accumulation of G1-
and S-phase cyclins (Clns and Clbs, respectively). This tran-
scriptional activation is driven by a positive feedback loop
(Skotheim et al., 2008) that makes Start an irreversible transition
(Charvin et al., 2010). The accumulation of S-phase cyclins is
necessary, but not sufficient, to initiate DNA replication becausethe activity of Cdk1:Clb complexes is initially masked by their
stoichiometric inhibitor, the Cyclin-dependent Kinase Inhibitor
(CKI) Sic1 (Schwob et al., 1994); note that the colon indicates
that Cdk1 and Clb are in a protein complex. The G1/S transition
is triggered by the proteolytic degradation of Sic1. Sic1 degrada-
tion is initiated by Cln:Cdk1 activity (Nash et al., 2001) and con-
tinues to be rapidly degraded by the Clb:Cdk1 kinases as they
become activated (Ko˜ivoma¨gi et al., 2011; Yang et al., 2013).
A transcriptional positive-feedback loop similar to the Start
network in yeasts operates at the restriction point in mammalian
cells (Bertoli et al., 2013; Cross et al., 2011). CyclinE:Cdk2 pro-
motesCyclinE transcription through activation of its transcription
factor (E2F) (Geng et al., 1996; Ohtani et al., 1995; Weinberg,
1995). A bistable switch generated by transcriptional feedback
makes the transition through the restriction point irreversible
(Yao et al., 2008). Following the transition past the restriction
point, E2F-mediated transcription leads to the accumulation of
both CyclinE and CyclinA, which form complexes with Cdk2, re-
sulting in its activation, which serves as the trigger for S-phase
entry. Similar to yeast, activation of Cdk2:S-phase Cyclin com-
plexes requires the proteolytic degradation of their stoichio-
metric CKIs, p27Kip1, and p21Cip1 (Sherr and Roberts, 1999).
The proteolytic double-negative feedback between CKI and
S-phase kinases in yeast leads to G1 and S being two discrete,
alternative states. Furthermore, this double-negative feedback
loop ensures that commitment to S phase in yeast is irreversible
(Chen et al., 2000; Cross et al., 2002; Verdugo et al., 2013; Yang
et al., 2013). While the core regulatory machinery (i.e., the pro-
teolytic double-negative feedback loop) of the G1/S transition
is conserved between yeast and man, this machinery has been
extensively elaborated upon. This elaboration is in the form of
many more regulatory components (Cyclins, CDKs, CKIs), with
sometimes partially overlapping functions, and additional inter-
actions between conserved components (Cross et al., 2011).
Thus, an unresolved question is whether the mammalian G1/S
transition exhibits similar system-level properties as yeast.
Answering this question is important not only to gain insight
into the mammalian G1/S transition, but also to understand
how particular behaviors observed in yeast, such as the irrevers-
ible switching between discrete states, can be retained when the
size and complexity of the regulatory networks governing these
behaviors increase during evolution.
Describing the systems-level interactions between Cdk2,
CyclinE, CyclinA, andCKI is also highly relevant to gaining insight
into the dysregulated G1/S progression of cancer cells, where
mutations and epigenetic events often conspire to increaseCell Systems 2, 27–37, January 27, 2016 ª2016 The Authors 27
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Figure 1. Quantifying the Dynamics of G1/S Regulators in Single Cells
(A) Stills taken from Movie S1 of HeLa cells stably expressing p27Kip1-GFP and LSS2-mKate-PCNA. Graph shows quantification of p27Kip1-GFP from individual
cells, aligned to the G1/S transition. Four independent measurements were taken, and 17 cells from one experiment are shown.
(B) Stills taken from Movie S2 of HeLa cells stably expressing CyclinE1-GFP and LSS2-mKate-PCNA. Graph shows quantification of CyclinE1-GFP from indi-
vidual cells, aligned to the G1/S transition. Three independent measurements were taken, and 15 cells from one experiment are shown.
(C) Stills taken from Movie S3 of HeLa cells stably expressing CyclinA2-GFP and LSS2-mKate-PCNA. Graph shows quantification of Cyclin A2-GFP from in-
dividual cells, aligned to the G1/S transition. Four independent measurements were taken, and 11 cells from one experiment are shown.
(legend continued on next page)
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CyclinE and downregulate p27Kip1 levels (Chu et al., 2008; Fero
et al., 1996; Hershko, 2010; Kiyokawa et al., 1996; Nakayama
et al., 1996; Scaltriti et al., 2011). Moreover, many cancer cells
do not have an intact restriction point (Asghar et al., 2015), and
thus, inhibition of the G1/S transition is an attractive therapeutic
target to stop these cancer cells from proliferating. To inhibit
S-phase entry effectively, we need a quantitative understanding
of how Cdk2 activity is a function of Cyclins, CKIs, and APC/C
components and how this drives cell-cycle progression.
Only a handful of studies have been able to describe the sys-
tems-level logic of progression through different cell-cycle
phases in mammalian cells (Pomerening et al., 2008; Yao
et al., 2008; Yuan et al., 2014), likely because it has been difficult
to quantify the levels and/or activity of different network compo-
nents at a single cell level. Single cell, time-lapse data are essen-
tial to generate predictive quantitative models because such
models require information not only on the signaling state of a
cell at a given time, but also regarding the cell’s history, which
is unattainable using population-based measurements.
Here we describe an experimental system to quantify the real-
time protein expression of key regulatory molecules involved in
the G1/S transition (CyclinA2, CyclinE1, and p27Kip1) and Cdk2
activity. We correlate these changes with cellular fate (initiation
of DNA replication) in single proliferating cells. We chose to
use HeLa cells as they are an excellent model for studying dys-
regulated G1/S progression as like almost all cancer cells, they
have lost the function of pRb (an inhibitor of E2F), do not have
an intact restriction point, and enter G1/S directly after cell divi-
sion (Moody and Laimins, 2010; Schwarz et al., 1985). We used
single cell imaging data of protein levels throughout the G1/S
transition to construct a mathematical model of this transition.
This work reveals that a switch-like G1/S transition is driven by
themutual antagonism between Cdk2 and p27Kip1. Furthermore,
our model provides a mechanistic explanation for how Emi1
keeps the G1/S transition irreversible to prevent DNA re-
replication.
RESULTS
Establishing a System to Analyze the Dynamics of the
G1/S Transition in Human Cancer Cells
We first sought to follow the dynamics of Cyclin and p27Kip1
expression in HeLa cells at the G1/S transition. We genetically
modified bacterial artificial chromosomes (BACs; Ciotta et al.,
2011; Hutchins et al., 2010) to generate GFP-tagged p27Kip1,
CyclinE1, and CyclinA2, under the control of their endogenous
promoters. These constructs were used to generate clonal cell
lines for this study (Figure S1A). Expression of all three reporters
mimicked the localization and expression of their endogenous
counterparts (Figures 1 and S1B–S1D), indicating that the
GFP tag did not affect their cell-cycle-mediated regulation.
Moreover, the GFP tag did not prevent S-phase entry or cell-
cycle progression (Figures S1E and S1F) and did not affect pro-
tein degradation rates (Figures S1G and S1H; timely degradation(D) Stills taken from Movie S4 of HeLa cells stably expressing the CDK2 senso
individual cells, aligned to the G1/S transition. Three independent measurements
curve is an individual cell. Time on images is shown in minutes and on graphs is sh
in green. Scale bars, 10 mm.of CyclinA2-GFP has been validated in den Elzen and Pines,
2001). Thus, our system accurately reflects Cyclin and p27Kip1
expression throughout the G1/S transition.
To correlate Cyclin and CKI expression with the G1/S transi-
tion, we co-imaged each GFP tagged protein with LSS2-
mKate-PCNA (Figures 1, S1C, and S1D; Movies S1, S2, and
S3). Fluorescently labeled PCNA is a robust and well-used
marker of DNA replication in mammalian cells (Essers et al.,
2005; Held et al., 2010; Leonhardt et al., 2000; Pomerening
et al., 2008) and does not interfere with cell-cycle progression
in our system. When cells enter S phase, PCNA fluorescence
rapidly increases and then switches to a punctate localization
(Figures 1A–1D, S1C, and S1D). Since the duration of G1 varies
between cells, LSS2-mKate-PCNA localization can act as a
marker to pseudo-synchronize cells at the G1/S transition, which
we define as time zero (Figures 1A–1C).
We next sought to define the temporal regulation of each of the
GFP tagged G1/S regulators throughout the G1/S transition.
Consistent with previous observations made in HeLa cell popu-
lations by western blotting (Carrano et al., 1999), we found that
p27Kip1-GFP is absent after cell division, accumulates rapidly,
and is then degraded, starting approximately 5–10 hr after
mitotic exit (Figure S1D). Through live single cell imaging, we
observed a decelerating pattern of p27Kip1-GFP accumulation
during G1 that strongly suggests that p27Kip1 degradation is
turned off after cell division. By imaging p27Kip1-GFP and
LSS2-mKate PCNA in the same cell, we saw that p27Kip1-GFP
was very rapidly degraded immediately prior to S-phase entry
(Figures 1A and S1D). Western blotting of synchronized cell
lysates did not show this rapid degradation because in a cell
population cells enter S phase at different rates (Figure S1G),
and thus, p27Kip1 degradation appears slow.
We observed that CyclinE1-GFP accumulates prior to the
G1/S transition and is only degraded after S-phase entry (Fig-
ure 1B), consistent with previous reports of CyclinE levels in
HeLa cell populations determined by western blotting of lysates
from synchronized cells (Dulic et al., 1992; Koff et al., 1992). Sin-
gle cell imaging also revealed that CyclinE1-GFP levels reach a
short plateau immediately after S-phase entry, consistent with
the plateau reached by endogenous CyclinE as detected by
western blotting (Yuan et al., 2014). Moreover, accumulation of
CyclinE1-GFP occurred in an accelerated fashion.
In contrast to CyclinE1-GFP, CyclinA2-GFP remained low dur-
ing G1, despite the fact that their common transcription factor
(E2F) was active during G1 (Figure 1C). Imaging of CyclinA2-
GFP showed that CyclinA2 protein only began to accumulate
in a linearmanner after theG1/S transition (Figure 1C), consistent
with previous reports from western blotting of HeLa cell lysates
(Pines and Hunter, 1990). This suggests that CyclinA2 is
degraded during G1.
Notably, the levels of CyclinE and CyclinA alone do not reveal
Cdk2 activity since Cyclin binding alone is not necessarily
sufficient to activate Cdks (reviewed in Morgan, 1997). To
measure Cdk2 activity, we generated a Cdk2 activity sensorr and LSS2-mKate-PCNA. Graph shows quantification of CDK2 activity from
were taken, and nine cells from one experiment are shown. In all cases, each
own in hours. Background shading on the graphs shows G1 in red and S phase
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Figure 2. Dynamics of theG1/S Transition in
HeLa Cells
(A) Influence diagram of G1/S regulatory network.
Both CyclinE and CyclinA, as well as Emi1 (Hsu
et al., 2002), are E2F target genes. The network
is characterized by multiple, mutual inhibitory
network motifs. (1) APC/CCdh1 promotes the
degradation of CyclinA, but Cdk2:CyclinA inhibits
APC/C activation by Cdh1 (Lukas et al., 1999;
Zachariae et al., 1998). (2) p27Kip1 inhibits both
Cdk2 kinase activities, but Cdk2:Cyclin complexes
promote p27Kip1 degradation directly and indi-
rectly, thereby creating a coherent feed-forward
loop. The direct effect is through phosphorylation
of p27 at T187 that targets p27Kip1 to the SCF-
proteasome system (Montagnoli et al., 1999;
Sheaff et al., 1997). The indirect effect is through
upregulation of the SCF component, Skp2 by in-
hibiting its degradation machinery, APC/CCdh1.
(B) The time courses for each of the cell-cycle re-
porters and Cdk2 activity was averaged across
all cells measured and aligned to S-phase entry
(time 0).
(C) Numerical simulation of the G1/S control
network with the deterministic version of themodel
(see Supplemental Experimental Procedures for
equations and parameter values).
(D) The steady-state dependence of p27Kip1 level on CyclinE and Emi1 (the diagram is computed in the absence of CyclinA since its level is low during the G1/S
transition) was calculated as a one-parameter bifurcation diagram with the deterministic version of the model. p27Kip1 can settle at high and low levels (solid
curves) at low and high CyclinE levels, respectively. The two states are separated by two different thresholds whose values are Emi1 dependent. The G1/S
transition is characterized by the drop from the high to low level of p27Kip1.(CDK2L-GFP), a slightly longer version of the recently published
DHB-Ven Cdk2 sensor (see Experimental Procedures; Gu et al.,
2004; Spencer et al., 2013). Briefly, this is a fluorescent sensor
of Cdk2 activity based on the C-terminal fragment of DNA Heli-
case B. When phosphorylated by Cdk2, the sensor leaves
the nucleus. By measuring the cytoplasmic:nuclear ratio of
CDK2L-GFP, we can obtain an estimate of Cdk2 kinase activity
from individual cells. First, we validated that CDK2L-GFP was a
specific reporter of Cdk2 activity in HeLa cells (Figures S2A–S2I).
As judged by our CDK2L-GFP sensor, Cdk2 kinase activity
abruptly increased at S-phase entry, followed by a second phase
of activity increase that occurs at a relatively slower rate (Fig-
ure 1D; Movie S4). We saw similar behavior if we used the
DHB-Ven Cdk2 activity sensor (Spencer et al., 2013) in HeLa
cells (Figure S2J). The abrupt increase in kinase activity was pre-
cisely correlated with the rapid decrease in p27Kip1-GFP (Figures
1A and 1D), suggesting that degradation of p27Kip1 may be rate
limiting in Cdk2 activation and S-phase entry. Immediately after
S-phase entry, we consistently observed a transient decrease in
Cdk2 activity (Figures 1D and S2J). In CyclinE1/2-depleted cells,
this decrease is more pronounced (Figure 3D). However, what
causes this dip in Cdk2 activity is currently not known and war-
rants further investigation. Taken together, these observations
describe key G1/S signaling events in single cells throughout
the G1/S transition.
Developing a Dynamical Model of the G1/S Transition
To understand how the observed dynamics of Cyclin, CKI and
Cdk2 activity emerge from the underlying molecular network,
we next generated a dynamical model of the G1/S transition in
human cells based on our live imaging data. Until now, the30 Cell Systems 2, 27–37, January 27, 2016 ª2016 The Authorsdynamical data necessary to parametrize such a model have
not been available, as the current literature provides information
only on the molecular mechanisms controlling the G1/S transi-
tion (Kohn, 1999). This G1/S molecular network involves multiple
interactions between Cdk2:CyclinA, Cdk2:CyclinE, p27Kip1, and
their regulators (Figure 2A).
We have used prior knowledge of the G1/S molecular network
to construct a stochastic mathematical model of the G1/S tran-
sition (see Supplemental Information for a detailed description of
rate expressions). Our model contains a considerable number of
kinetic parameters (25) that are largely unknown in the current
literature, except for the half-lives of some mRNAs and proteins
(Schwanha¨usser et al., 2011). The unknown rate constants were
estimated by comparing deterministic simulations of the model
(Figure 2C) with averaged time courses of pseudo-synchronized
cell-cycle regulators (Figures 2B and S3A) in a brute-force
approach.
In our model, active E2F leads to an accumulation of CyclinE
protein early in G1 (Figures 2C and S3B), in the absence of func-
tional pRb in HeLa cells (Moody and Laimins, 2010; Schwarz
et al., 1985). However, CyclinE accumulation is insufficient to
drive progression into S phase as Cdk2:CyclinE activity is in-
hibited by its stoichiometric CKI, p27Kip1, whose degradation,
dependent on Cdk2 and SCFSkp2 activities (Sheaff et al., 1997),
is slow at low Cdk2 activity and low Skp2 levels. Once sufficient
CyclinE accumulates, Cdk2:CyclinE activity overcomes p27Kip1
inhibition. The activated Cdk2:CyclinE targets p27Kip1 for protea-
some-dependent degradation through phosphorylation of T187
on p27Kip1 (Mu¨ller et al., 1997; Sheaff et al., 1997; Vlach et al.,
1997). With the degradation of p27Kip1, more Cdk2:CyclinE is
released, and p27Kip1 degradation is further enhanced. The
fast positive feedback results in the abrupt degradation of
p27Kip1. After the abrupt degradation of p27Kip1, Cdk2:CyclinE
kinase becomes activated (Figures 2C and S3B).
In our model, despite the activation of CyclinA protein synthe-
sis, the level of CyclinA is kept low in G1 phase by APC/CCdh1-
mediated degradation (Figures 2C and S3B; Geley et al., 2001;
Lukas et al., 1999; Sørensen et al., 2001). Accumulation of
CyclinA does not start until inactivation of APC/CCdh1. At the
end of G1, APC/CCdh1 is inactivated due to the accumulation
of Emi1 (Hsu et al., 2002; Miller et al., 2006) and phosphorylation
of Cdh1 byCdk2 (Keck et al., 2007; Lukas et al., 1999). This leads
to accumulation of Skp2 (Bashir et al., 2004; Wei et al., 2004).
The degradation of phosphorylated p27Kip1, which is dependent
on SCFSkp2-dependent poly-ubiquitylation, is further acceler-
ated by Skp2 accumulation in late G1 (Figure S3C).
All of these events—p27Kip1 degradation, Cdk2 activation, and
CyclinA accumulation—coincide with the G1/S transition. This
leads to the phosphorylation-dependent degradation of CyclinE
protein by Cdk2 (Won and Reed, 1996). A linear combination of
the model-calculated free Cdk2:Cyclin complexes (Figure 2C)
therefore approximates the Cdk2 activity, as measured by our
Cdk2 sensor (Figure 2B).
Our model explains the switch-like characteristic of the G1/S
transition by mutual inhibition among cell-cycle regulators, with
a central role for p27Kip1. The abrupt degradation of p27Kip1
has a critical threshold and fast protein turnover requirement.
In our model, the threshold originates from the antagonistic inter-
action between p27Kip1 and Cdk2:Cyclin complexes, which cre-
ates a bistable switch with the following characteristics. (1) The
steady-state level of p27Kip1 can be either high or low depending
on CyclinE levels, but intermediate steady-state levels are unsta-
ble (Figure 2D). (2) The transition from a high to low p27Kip1 level
takes place at a higher threshold of CyclinE than the opposite
transition. Therefore, G1/S control possesses the property of
hysteresis. (3) The threshold of CyclinE at which transitions occur
is dependent on the levels of Emi1 that inhibit APC/CCdh1 and
thereby upregulate Skp2 (Figure 2D). At the beginning of the
cycle when both CyclinE and Emi1 levels are low, the thresholds
are high, p27Kip1 is attracted to the upper steady state, and its
level rises (red curve in Figure 2D). (4) During G1, E2F-dependent
transcription drives the increase in both CyclinE and Emi1
protein levels. Thus, CyclinE and Emi1 could act synergistically
to remove p27Kip1. CyclinE levels reach the upper threshold
at a relatively low level of Emi1 that drives the cell through
G1/S into a state of low p27Kip1 (Figure S3D). (5) After the G1/S
transition, CyclinE levels start to decrease, but the cell stays in
the low p27Kip1 regime because the thresholds are also
decreasing through Emi1 accumulation (Figure S3D). The contin-
uous decrease of the thresholdsmakesG1/S an irreversible tran-
sition in the model.
Critically, our stochastic model captures the observed dy-
namics of G1/S regulators in HeLa cells (compare Figure S3A
with S3B) and thus provides a suitable framework by which to
make novel predictions regarding the mechanisms that underlie
the dynamical nature of the G1/S transition.
Degradation of p27Kip1 Is Driven by Cdk2 Activity
Our model of the G1/S regulatory network attributes the abrupt
decrease of p27Kip1 to fast protein turnover regulated by directand indirect double-negative feedback loops between p27Kip1
and Cdk2. Specifically, activated Cdk2 promotes p27Kip1 degra-
dation. Our model also implies that Cdk2 is required to keep the
level of p27Kip1 low after G1/S. Inhibition of Cdk2 should lead to
re-accumulation of p27Kip1 (Figure S3E). To test this prediction,
we treated HeLa cells, arrested in early S phase by a thymidine
block, with a Cdk1/2 inhibitor. In S-phase-arrested cells,
p27Kip1 levels are negligible. However, upon addition of Cdk1/2
inhibitor, p27Kip1 rapidly re-accumulated (Figure S3F). This rapid
re-accumulation of p27Kip1 suggests that its synthesis (transcrip-
tion and translation) is still active during DNA replication. More-
over, the low level of p27Kip1 after G1/S transition is indeed
maintained by high Cdk2 activity promoting p27Kip1 degradation.
Therefore, our model correctly predicts that a low level of p27Kip1
is maintained throughout S phase by high Cdk activity.
CyclinE Controls the Timing of the G1/S Transition
Stochastic model simulation with reduced levels of residual
CyclinE synthesis suggests that the G1/S transition is delayed
if CyclinE levels are depleted in G1 (compare the red and gray
p27Kip1 curves on Figure 3A). However, the rapid degradation
of p27Kip1 and the abrupt activation of Cdk2 are conserved
even after CyclinE depletion. The abruptness of p27Kip1 degra-
dation in the absence of CyclinE can be attributed to the mutual
antagonism between Cdk2:CyclinA and its inhibitor p27Kip1 (Fig-
ure 2A). The steady-state level of p27Kip1 shows a similar
Z-shaped dependence on the levels of CyclinA (not shown).
The two CyclinA thresholds, where p27Kip1 decreases or rises,
are Emi1 dependent because Emi1 inhibits APC/CCdh1 to upre-
gulate Skp2 levels (Figure 3B). The model predicts that the
‘‘path’’ during the G1/S transition is different for control siRNA-
treated cells (Figure S3D) and CyclinE-depleted cells (Figure 3B).
In control siRNA cells, CyclinE and Emi1 accumulate simulta-
neously. Since Emi1 is low, APC/CCdh1 is largely active, and
Skp2 level is low. Therefore, a large amount of CyclinE is
needed (>0.6 arbitrary units [a.u.]) to trigger p27Kip1 degradation.
In CyclinE-depleted cells, Emi1 accumulates first, leading
to APC/CCdh1 inactivation and subsequent accumulation of
CyclinA. In the presence of a high level of Emi1, inactive APC/
CCdh1 and a high level of Skp2, a low level of CyclinA (approxi-
mately 0.2 a.u.) is sufficient to trigger p27Kip1 degradation.
Consistent with our model prediction, siRNA-mediated deple-
tion of CyclinE delayed the degradation of p27Kip1, activation of
Cdk2, and initiation of S phase (compare the gray with the red
and black curves on Figures 3C and 3D, respectively; see also
Figures S4A and S4B). In addition, the abrupt degradation of
p27Kip1 and abrupt activation of Cdk2 remained intact after
CyclinE depletion (Figures 3C and 3D). Together, our results sug-
gest that although CyclinE is dispensable for the initiation of DNA
replication (Geng et al., 2003) CyclinE does play a role in the
timing the G1/S transition and thus is rate limiting.
CyclinA Is Dispensable for the Timing of G1/S Transition
Stochastic model simulation with reduced levels of CyclinA sug-
gests no change in the timing of the G1/S transition (compare the
red and gray p27 curves on Figure 4A). In addition, the simulation
suggested that neither p27Kip1 degradation nor Cdk2 activation
showed any delay relative to control cells and that these events
also kept their close association with the G1/S transition. TheseCell Systems 2, 27–37, January 27, 2016 ª2016 The Authors 31
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Figure 3. G1/S Transition in CyclinE1,2-
Depleted Cells
(A) Stochastic simulations of G1/S transition with
5% residual CyclinE synthesis (with 20-fold in-
crease in mRNA degradation rate). Relative
p27Kip1 levels and free Cdk2:Cyclin complexes are
shown.
(B) The CyclinA thresholds for p27Kip1 inactivation
and reactivation are plotted as a function of Emi1
levels with the deterministic model. The diagram is
divided into three territories: low (green) and high
(red) levels of p27Kip1 and bistability (gray) where
both of these states coexist. The trajectory of cell-
cycle progression of CyclinE1/2-depleted cells is
shown by a blue dashed curve.
(C and D) Time courses of p27Kip1-GFP level (C)
and Cdk2 activity (D) in individual CyclinE1/2-
depleted (color curves) and control siRNA-treated
cells (gray curves). Both time courses are plotted
from cell division, and S-phase entry is marked by
a diamond on each curve. In (C), three indepen-
dent experiments were conducted, and 8 (control
siRNA) and 11 (CyclinE1/2 siRNA) cells are shown
from one experiment. In (D), two independent ex-
periments were conducted, and 10 (control siRNA)
and 7 (CyclinE1/2 siRNA) cells are shown from one
experiment.simulation results are consistent with our experimental testing, in
which CyclinA is depleted by siRNA (compare the gray with the
red and black curves on Figures 4B and 4C, respectively; see
also Figures S4A and S4C).
Since CyclinA does not control the timing of the G1/S transi-
tion, the observation that different cells enter S phase at different
times is unlikely due to their different levels of CyclinA. Based on
our stochastic simulations (Figure 4A), we predict that the sto-
chastic expression of other G1/S regulators (for example CyclinE
or Emi1) is responsible for the variability in timing of the G1/S
transition in CyclinA-deficient cells.
Emi1 Ensures an Irreversible G1/S Transition
Oneway to ensure that DNA is replicated once and only once per
cell cycle is to make the G1/S transition difficult to reverse. Intu-
itively, we might predict that by binding and activating Cdk2
CyclinA could maintain an S-phase state after CyclinE is
degraded. However, our model simulations predict that CyclinA
depletion in S-phase cells is not sufficient to trigger re-accumu-
lation of p27Kip1 and thus reset cells into G1. In contrast, our
model suggests that Emi1 is both necessary and sufficient to
maintain the post-G1 state. Specifically, our model predicts
that increasing levels of Emi1 during S phase decrease the
amount of CyclinE required to maintain p27Kip1 degradation
(Figures 2D and S3D). If we remove Emi1 from S-phase cells in
the model, APC/CCdh1 is activated, CyclinA and Skp2 are
degraded, and p27Kip1 and CyclinE re-accumulate. Later,
increasing CyclinE causes a second round of p27Kip1 degrada-
tion, and the cells could re-enter S phase once again (Figures
5A and S5A).
To test our model prediction, we synchronized cells in early
S phase (with a double thymidine block) and depleted Emi1 by
RNA interference during release from the first thymidine block,
such that Emi1 would be depleted in the next cell cycle (Fig-32 Cell Systems 2, 27–37, January 27, 2016 ª2016 The Authorsure S5B; see Supplemental Experimental Procedures). Control
siRNA-treated cells undergo mitotic cycling, confirmed by fluo-
rescence-activated cell sorting (FACS) (Figure 5B) and the tem-
poral patterns of cell-cycle regulators (see Figures S5C–S5F). In
contrast, Emi1 depletion leads to re-replication of DNA, as previ-
ously reported (Figure 5B; Di Fiore and Pines, 2007;Machida and
Dutta, 2007). This suggests that Emi1 is required to maintain an
irreversible G1/S transition.
Consistent with our model prediction, the experimental data
clearly show a short-lived increase then degradation of
CyclinA2-GFP (Figure 5C), followed by transient accumulation
of p27Kip1-GFP (Figure 5D), and re-accumulation of CyclinE1-
GFP (Figure 5E). This accumulation of CyclinE1 protein is likely
due to a combination of a low level of Cdk2 activity since
CyclinE1-GFP is stabilized when Cdk2 activity is inhibited (Fig-
ure S6A) and high E2F activity as cells return to a G1-like state.
Direct measurements of Cdk2 activity in Emi1-depleted cells
show an initial small increase in kinase activity after release
from the thymidine block, followed by a decrease. In the majority
of cells, this decrease is small and is followed by a plateau in
Cdk2 levels at an intermediate level of between 1 and 1.5 (Fig-
ure 5F). However, in some cells, this dip in Cdk2 activity is
more pronounced. The activity of Cdk2 in any individual Emi1-
depleted cell will depend on (1) the level of Emi1 depletion and
(2) the relative amounts of CyclinE and CyclinA when Emi1 is
depleted in that cell. Therefore, cells with a larger dip in Cdk2 ac-
tivity may reflect cells with a better Emi1 depletion and/or a
higher ratio of CyclinA to CyclinE when Emi1 is depleted.
This begs the question of how DNA re-replicates after Emi1
depletion. Notably, we do not observe endoreduplication after
Emi1 depletion (Figure 5B; no discrete peak is seen at 8n; at
200K on the x axis). If we image PCNAdynamics in cells depleted
of Emi1, we can observe nuclei switching between G1 and S in
the absence of mitosis and nuclei increasing in size (Figure S6B;
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Figure 4. G1/S Transition in CyclinA-Depleted Cells
(A) Stochastic simulations of the G1/S transition with 5% residual CyclinA
synthesis (with 20-fold increase in mRNA degradation rate).
(B and C) Time courses of p27Kip1-GFP level (B) and Cdk2 activity (C) in indi-
vidual CyclinA2-depleted (color curves) and control siRNA-treated cells (gray
curves). Both time courses are plotted from cell division, and S-phase entry is
marked by a diamond on each curve. In (B), three independent experiments
were conducted, and ten (control siRNA) and nine (CyclinA2 siRNA) cells are
shown from one experiment. In (C), two independent experiments were con-
ducted, and ten (control siRNA) and ten (CyclinA2 siRNA) cells are shown from
one experiment.Movies S5 and S6). However, PCNA foci in Emi1-depleted cells
are not discrete, as in control siRNA-treated cells, and S-phase
entry is more noticeable by changes in the ‘‘texture’’ of PCNA
localization throughout the nucleus (Movie S6). This implies
that after Emi1 depletion, cells do not progress through ‘‘early,’’
‘‘mid,’’ and ‘‘late’’ DNA replication stages, but instead likely sit atthe boundary of G1 and S, refiring some DNA replication origins.
Loss of Geminin after Emi1 depletion (Di Fiore and Pines, 2007;
Machida and Dutta, 2007) would permit origin refiring. This is
also consistent with recent data suggesting uncontrolled reacti-
vation of replication origins after Emi1 depletion (Neelsen et al.,
2013). Altogether, our data suggest that S-phase cells depleted
of Emi1 can transiently return to a G1 state (low CyclinA, high
p27Kip1, accumulating CyclinE) before recommitting to DNA syn-
thesis, supporting our model prediction that Emi1 maintains the
irreversibility of the G1/S transition.
DISCUSSION
Our model suggests that the abrupt degradation of p27Kip1 is the
result of a rapid proteolytic double-negative feedback loop
between Cdk2:CyclinE and p27Kip1. This fast degradation of
p27Kip1 ensures a rapid activation of Cdk2 and immediate
S-phase entry. We propose that p27Kip1 degradation is rate
limiting in S-phase entry in HeLa cells. Indeed, this is consistent
with previous reports using siRNA to deplete p27Kip1 (Sabile
et al., 2006; Yuan et al., 2014). Thus, even though the proteolytic
double-negative feedback loop between a Cdk:Cyclin complex
and a CKI is embedded within a more complex architecture in
HeLa cells than in yeast, it is sufficient to explain the temporally
abrupt switching between two discrete cell-cycle states.
While the feedback between Cdk2:CyclinE and p27Kip1 is suf-
ficient to explain the switch-like transition between G1 and
S phases, our model predicts that the transition is made globally
irreversible by Emi1 accumulation. In support of this, we observe
that single S-phase cells depleted of Emi1 re-express p27Kip1,
accumulate CyclinE, degrade CyclinA, and appear to engage
in simultaneous licensing and firing of replication origins, which
are normally temporally distinct behaviors (Figure 5B). It is also
formally possible that Emi1-depleted cells are activating a
checkpoint that leads to the stabilization of p27Kip1. However,
since p27Kip1 expression is not sustained in the presence of
continuous Emi1 depletion and we observe DNA re-replication,
we do not think that this is the case.
In marked contrast to MCF10A and fibroblast cell lines, where
populations exhibit heterogeneous Cdk2 dynamics and exist in
either Cdk2high or Cdk2low states (Spencer et al., 2013), HeLa
cells are homogeneous in terms of their pattern of Cdk2 activity.
HeLa cells lack restriction point control due to expression of
E6 and E7 proteins from integrated HPV-18, which inactivate
p53 and pRb, respectively (Boshart et al., 1984; Butz et al.,
1995) and also overexpress c-Myc (Du¨rst et al., 1987; Lazo
et al., 1989). By extending our model to include pRb control
over E2F activity, the differences between HeLa versus
MCF10A and fibroblast cell lines can be explained. This sug-
gests that the model may be generalizable to explain some of
the differences between cancer and non-transformed cells. In
non-transformed cells growing in the presence of intermediate
levels of mitogens, the decision between proliferation and G1 ar-
rest ismade at the end of the previous cycle (Overton et al., 2014;
Spencer et al., 2013). pRb phosphorylation by E2F-induced
Cdk2:Cyclin complexes creates additional amplification loops
within the network (Figure 6A), with low and high Cdk2:CyclinE
activity states (Figure 6B). Whether dividing cells adopt a
Cdk2high or Cdk2low fate depends on the mutual antagonismCell Systems 2, 27–37, January 27, 2016 ª2016 The Authors 33
A B
C D
E F
Figure 5. Emi1 Is Required for an Irreversible
G1/S Transition
(A) Stochastic simulation of Emi1 depletion. The
initial state of the model corresponds to an S-phase
cell (CyclinA increasing, CyclinE decreasing, and
p27Kip1 level is low, see Figure 2C). At t = 5h, the
level and rate of synthesis of Emi1 were reduced
by 90%, causing APC/CCdh1 reactivation, loss of
CyclinA, and accumulation of p27Kip1 and CyclinE.
Later, the re-accumulation of CyclinE promotes the
re-degradation of p27Kip1.
(B) DNA re-replication after Emi1 depletion. FACS
plots of control (left) and Emi1-depleted (right) cells
at 0, 24, and 48 hr after release from thymidine.
Numbers shown on each graph are the percentage
of cells with DNA > 4n.
(C) Experimental measurement of CyclinA2-GFP in
Emi1-depleted cells. CyclinA2-GFP levels continue
to increase at the beginning of the experiment,
possibly since Emi1 is still functional. Later,
CyclinA2-GFP levels decrease and remain low due
to reactivation of APC/CCdh1 in the absence of Emi1.
Two independent measurements were taken, and
ten cells from one experiment are shown.
(D) Experimental measurement of p27Kip1-GFP in
Emi1-depleted cells. p27Kip1-GFP is initially low and
then shows a transient increase in some cells. Two
independent measurements were taken, and eight
cells from one experiment are shown.
(E) Experimental measurement of CyclinE1-GFP in
Emi1-depleted cell. CyclinE1-GFP initially de-
creases and then continues to accumulate for the
duration of the experiment. Two independent
measurements were taken, and ten cells from one
experiment are shown.
(F) Quantification of Cdk2 activity in Emi1-depleted
cells. Two cells show a significant dip in Cdk2 ac-
tivity. Other cells show a more moderate decrease.
In all cases, individual curves represent individual
cells. Three independent measurements were
taken, and 11 cells from one experiment are shown.between CKIs and the residual Cdk activity after degradation of
CyclinA and CyclinB during mitosis. Cdk2:CyclinE activity is the
most significant in this context, and if it is high relative to CKI-
mediated inhibition, cells progress into S phase (Figure 6C). In
the opposite scenario, high CKI and low Cdk2:CyclinE activity
leads to pRb-dephosphorylation, E2F inactivation, and G1 arrest
(Figure 6D).
Perhaps because HeLa cells lack functional pRb, they exist
in a single signaling state that leads to S-phase commitment
in all cells. We suggest that this homogeneity may be an impor-
tant aspect in oncogenesis, as the lack of bifurcation into
CDKhigh or CDKlow states would ensure that the majority of
cells in a tumor have a high probability of proliferating, resulting
in increased tumor fitness. In contrast, if a subpopulation of
a tumor frequently entered a CDK2low state, this would
decrease the fitness of the population as a whole. However,
evolving homogeneity in S-phase commitment during onco-
genesis may come at a price, as the signaling networks regu-
lating the G1/S transition exist in a single (attractor) region in
signaling state space and thus are less robust to inhibition of
components necessary for that state. Homogeneity in the34 Cell Systems 2, 27–37, January 27, 2016 ª2016 The Authorssignaling state of the G1/S network across cancer cells may
explain the somewhat counterintuitive observations that some
cancer cells are more dependent on key cell-cycle regulators,
such as Cdk2 and CyclinE, than non-transformed cells (Martı´n
et al., 2005; Tetsu and McCormick, 2003; van den Heuvel and
Harlow, 1993).
In future studies, it will be important to determine whether the
systems that regulate G1/S are similar in other cancer cell
models that lack restriction point control in order to gain mech-
anistic insight into cell-cycle regulation. Ultimately, different
patients may be stratified not only on the basis of genotypic dif-
ferences, but also on predicted differences in both the architec-
ture and dynamics of their regulatory networks.
EXPERIMENTAL PROCEDURES
Generation of Fluorescently Tagged BACs and Reporters
BACs used in this study were ordered from BACPAC Resource center
(CHORI). BACs used are p27Kip1 RP11-70N14, CCNE1 RP11-345J21, and
CCNA2 RP11-768B18. All BACs were verified by PCR using verification
primers as listed on the Mitocheck website (http://www.mitocheck.org). Pro-
teins of interest were tagged using BAC Recombineering at their C-termini
A B
C D
Figure 6. G1 Progression in Cells with an
Intact Restriction Point
(A) G1 control in cells with an intact restriction point
including pRb control over E2F activity, as well E2F
autoregulation.
(B) The steady-state levels of CyclinE (blue) and pRb
(red) in the extended model are plotted against each
other. Low hypo-phosphorylated pRb corresponds
to high E2F activity. These balance curves of CyclinE
and hypo-phosphorylated pRb create two qualita-
tively different steady states (high CyclinE, low pRb
labeled ‘‘High’’ and low CyclinE, high pRb labeled
‘‘Low’’) after cell division. The existence of two
different cellular states (fates) is largely dependent on
the inverse N-shaped characteristic of the pRb-bal-
ance curve (red) caused by the antagonism between
Cdk2:CyclinE and CKI. In the absence of CKI, the red
curve becomes a hyperbole, and the bistable regime
is much reduced. The ‘‘dividing the way’’ behavior is
illustrated by two trajectories (dotted arrows).
(C and D) Temporal evolution of free Cdk2:CyclinE (C)
as well as E2F and hypo-phosphorylated pRb (D) in a
cell approaching high and low Cdk2 activity states.with localization and affinity purification (LAP) tags that contain GFP and an
affinity purification tag (Poser et al., 2008). Primers used to tag BACs were
those listed on the Mitocheck BACFinder website (http://www.mitocheck.
org/cgi-bin/BACfinder). Successful recombination and tagging of genes was
confirmed by PCR followed by DNA sequencing.
PCNA was tagged at the N terminus with the modified LSS2-mKate fluoro-
phore to generate LSS2-mKate-PCNA (Piatkevich et al., 2010).
To measure CDK2 activity, we used a similar strategy, now described
in Spencer et al. (2013). We cloned the C-terminal PSLD region of Human
DNA Helicase B (DHB; 957-1087 amino acids of DHB) into pIRES-GFP
Puro3 to generate CDK2L-GFP. Note that this sensor is slightly longer than
that used in Spencer et al. and is similar to the one first described in Gu
et al. (2004).
Live Cell Imaging
Live cell imagingwas performed using a Zeiss LSM710 confocal, with a 403 oil
objective, NA 1.3, or a High-content Opera Spinning disk confocal microscope
(PerkinElmer), with a 403 water objective, NA 0.9. All live cell imaging was
carried out in a humidified environmental chamber maintained at 37C and
5% CO2.
Quantification of Reporters
All imaging data was quantified in Volocity (PerkinElmer). To find dynamic
changes in GFP intensities, cell nuclei were tracked using the LSS2-mKate-
PCNA signal and the Shortest Path algorithm. A maximum distance of 9 mm
between nuclei in consecutive timeframes was used to eliminate erroneous
tracks. For p27Kip1-GFP, CyclinE1-GFP, and CyclinA2-GFP, nuclear levels of
protein were quantified since all three proteins had an exclusively nuclear
localization during G1 and S. In each cell, the average value of pixel intensities
was calculated, and average background fluorescence was subtracted. All
fluorescence intensities were normalized to peak levels. Timing of S-phase en-
try was determined manually from PCNA fluorescence images. Specifically, S-
phase entry is defined by a sharp increase in PCNA intensity, often coinciding
with the appearance of nucleoli.
For CDK2L-GFP and DHB-Ven quantification, nuclear intensity was
measured by taking a region of interest (ROI) inside the nucleus, and cyto-
plasmic intensity was measured as the ring region around the nucleus. Cdk2
activity was then measured as the ratio between the ring GFP intensity to
the nuclear GFP intensity.
Additional experimental procedures are provided in Supplemental
Information.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and six movies and can be found with this article online at http://
dx.doi.org/10.1016/j.cels.2016.01.001.
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